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This paper presents a deterministic model for Neisseria meningitidis, a bacterium that
causes meningitis. The model was parameterized using data from the 2017 meningitis
outbreak in Nigeria. Optimal control theory was applied to investigate the optimal strategy
for curtailing the spread of the disease using control variables determined from sensitivity
analysis. These control variables are personal-protection such as the use of facial masks,
and vaccination. The results show that the two controls avert more infections at low costs.
Furthermore, a reciprocal relationship exists between the use of facial masks and vaccine.
That is, when the use of facial masks is high, the use of vaccine is low and vice versa.
Cost-effective analysis was applied to investigate the most cost-effective strategy from
various combination of control strategies. The results show that strategy combining all the
control variables is the most cost-effective strategy followed by the strategy involving both
personal-protection, the vaccination-only strategy was the least cost-effective. Although
vaccination strategy is not cost-effective in this study, it is as effective in curtailing the
infection as the other two control strategies. The study suggests that governments of
communities with limited resources should consider complementing the use of vaccine
with the use of facial mask particularly in hard-to-reach places in their communities.
© 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi
Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neisseria meningitidis is a gram-negative diplococcus bacterium that causes meningitis and other meningococcal diseases
(Centers for Disease Contr, 2015; Rouphael & Stephens, 2012). The bacteria is transmitted person-to-person via droplets of
respiratory or throat secretions from carriers (World Health Organization, 2017b). Healthy individuals who have had close
and prolonged contact with an infected individual can be infected with the bacteria. For example, closed and prolonged
contact such as kissing, sneezing, or coughing or living in close quarters (household crowding), sharing eating or drinking
utensils can lead to infection (Centers for Disease Contr, 2015; World Health Organization, 2017b). The bacteria colonize the
nasopharynx or pharyngeal of carriers (Centers for Disease Contr, 2015; Hitchcock, Robinson, & Neisseriae, 1993, p. 229;
Rouphael& Stephens, 2012) and can sometimes overwhelm the body's defensive system, spreading into the bloodstream and).
unications Co., Ltd.
ting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the
icenses/by-nc-nd/4.0/).
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coccemia infection state occurs when the bacteria cause a bloodstream infection. About 10% to 20% of individuals are esti-
mated to be Neisseria meningitidis carriers, but this number may be higher during epidemics outbreaks (World Health
Organization, 2017b). The incubation period of the diseases is about 3e4 days but may vary between 2 and 10 days
(Centers for Disease Contr, 2015; World Health Organization, 2017b). The fatality rate is about 10%e15%, and the meningo-
coccemia infections can reach up to 40% (Centers for Disease Contr, 2015).
The meningococcal disease is found worldwide; however, the “meningitis belt” of sub-Saharan Africa has the highest
number of occurrences worldwide (Centers for Disease Contr, 2013). The “meningitis belt” stretches from Senegal to Ethiopia
and include countries like Benin, Burkina Faso, Burundi, Cameroon, Côte d’Ivoire Eritrea, Ethiopia, Gambia, Ghana, Guinea,
Guinea Bissau, Kenya, Mali, Mauritania, Niger, Nigeria, Uganda, Central African Republic, Democratic Republic of Congo,
Rwanda, Senegal, Sudan, South Sudan, Tanzania, Chad, and Togo (Centers for Disease Contr, 2013; World Health Organization,
2017b).
The highest incidence of meningitis occurs during the dry season fromDecember to July when dry winds loaded with dust
combine with the cold night and the occurrence of upper respiratory tract infection damage the nasopharyngeal mucosa.
These combined events increase the risk of meningococcal disease (Centers for Disease Contr, 2012; Greenwood,
Blakebrough, Wali, & Whittle, 1984; Sabatini et al., 2012; World Health Organization, 2017b). Also, N. meningitidis trans-
mission could be facilitated by large population displacements and by pilgrimages and traditional markets at regional levels
(Sabatini et al., 2012;World Health Organization, 2017b). All these factors put togethermay explain the large epidemics which
occurs during the dry Harmattan season in the meningitis belt (Sabatini et al., 2012; World Health Organization, 2017b).
Harmattan is a season in West African, which happens from November ending to mid-March (Encyclopdia Britannica and I,
2018; Minka& Ayo, 2014). The season is characterized by the dry and dusty northeasterly trade wind, which blows overWest
Africa from the Sahara Desert into the Gulf of Guinea (Encyclopdia Britannica and I, 2018).
There are 12 identified serogroups, 6 of which are known to cause epidemics, these are namely the A, B, C, W135, X and Y
serogroups (Centers for Disease Contr, 2015; Rouphael & Stephens, 2012; World Health Organization, 2017b). In Nigeria, N.
meningitidis strains A and C are the dominant subgroups. A major outbreak of strain A occurred in Nigeria in 2009 with over
55,000 cases which resulted in about 2500 deaths (World Health Organization, 2017d). And since 2013 Nigeria has been
experiencing large outbreaks of meningitis C; in 2015, over 2500 cases of the disease were reported. The current 2017
outbreak has led to over 9902 cases with over 602 deaths (Nigeria Centre for Disease Control (NCDC), 2017b).
Neisseria meningitidis is treatable and preventable and vaccines are the cornerstone of prevention and control of the
bacteria (Centers for Disease Contr, 2012). Capsular polysaccharide vaccines used to prevent N. meningitidis have been
available and used since the 1970s (Centers for Disease Contr, 2012). These include a bivalent vaccine which prevents the
serogroups A and C infections, a trivalent vaccine (against serogroups A, C, and Y) and a tetravalent vaccine (against
serogroups A, C, Y, and W135). However, like with any vaccine, meningococcal vaccines are not 100% effective.
In this study, we develop amathematical model with an imperfect vaccine. We use sensitivity analysis to detect the model
parameters whose variability has the strongest impact on the diseases' reproduction number. From these parameters we
select two (namely the use of facial masks and vaccination) and use them as time-dependent control variables. To the best of
our knowledge, this study is the first work to uniquely identifies facial masks as means to control Neisseria meningitidis. The
with the aid of optimal control theory, we investigate the impact of these two variables on diseases transmission, that is, we
determine the associated optimal control pair. We also investigate the cost-effectiveness of these control variables using cost-
effectiveness analysis.
2. Model formulation
The model is derived as follows: the population is divided into susceptible (S), vaccinated (V), carrier (C), infectious (I), and
Recovered (R) classes. Therefore, the total population at a given is time NðtÞ ¼ SðtÞþ VðtÞþ CðtÞþ IðtÞþ RðtÞ.
Individuals move from one class to the other as the disease progresses according to their disease status. The susceptible
class (S) is populated by new recruits from three classes: 1) either via birth or immigration of susceptible individuals at the
rate P; 2) from the recovered individuals with loss of immunity at the rate k;; and 3) from those individuals whose vaccine
had waned at the rate u. We further assumed that there is no entry of the infectious into the population either by vertical
transmission or immigration; thus, the new inflow into the population does not enter the infectious classes. All individuals,
whatever their status, are subject to natural death, which occurs at the rate m. The susceptible population is reduced by
infection following effective contact with infected individuals at the rates lðtÞ, defined by
lðtÞ ¼ b½hCðtÞ þ IðtÞ
NðtÞ : (1)
The parameter b is the effective transmission probability per contact and the parameters h  1 is a modification parameter
that indicates the infectivity of individuals in the carrier class. The susceptible population is further reduced by constant
vaccination. That is, susceptible individuals, move to the vaccinated class at the constant rate n. Since themeningitis vaccine is
highly effective but not 100% effective we assume that the vaccinated population is reduced by infection at the rates ð1 εÞl,
where 0 ε  1: The parameter ε gives the measure of the vaccine efficacy. For example, ε ¼ 1 indicates that the vaccine is
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ulation is reduced by infection at the rates ð1 εÞl, where 0 ε  1: The parameter ε gives themeasure of the vaccine efficacy.
For example, ε ¼ 1 indicates that the vaccine is 100% effective.
When individuals in both susceptible and vaccinated classes are infected they move into the carrier class (CðtÞ). This class
is reduced by disease progression to the infectious class (IðtÞ) at the rate s or by recovery at the rate gC to the recovered class
(RðtÞ) or by natural death at rate m:
Individuals in the infectious class increase due to disease activation in the carrier class, the population decreases by re-
covery at the rate gI and disease-induced death at the rate d. The recovered class is populated by recoveries from both the
carrier and infectious classes and reduced due to loss of immunity.
Hence, from the above descriptions and assumptions, the system of nonlinear differential equations describing the
transmission dynamics of meningitis in the population is given as
dS
dt
¼PþuV þ kR lðtÞS nSmS
dV
dt
¼ nSð1 εÞlðtÞV ðuþmÞV
dC
dt
¼ lðtÞSþð1 εÞlðtÞV ðsþgC þmÞC
dI
dt




(2)The descriptions of the model parameters are given in Table 1 and the model flow-diagram is given in Fig. 1.
2.1. The basic reproduction number
The basic reproduction number (R 0) of the meningitis model (2) is given below. The reproduction number, R 0, is the
number of secondary infections in an entirely susceptible population due to infections from one introduced infectious in-
dividual withmeningitis. IfR 0 <1, the diseasewill die out in the community and ifR 0 >1 it will persist. The theoretical study
of the model basic properties are presented in Appendix A, and the calculations to derive the expression of R 0 are given in
Appendix B.
The reproduction number is given as
R 0 ¼
b½hðgI þ mþ dÞ þ s½uþ mþ nð1 εÞ
ðsþ gC þ mÞðgI þ mþ dÞðuþ mþ nÞ
:
In the absence of vaccine (i.e., n ¼ 0) R 0 reduces to ~R 0 given in equation (4) below. The quantity ~R 0 is the reproduction
number in the worst-case scenario when intervention like vaccination is absent.Table 1
Description and values of the parameters of the meningitis models (2) and (3).
Parameter Definition Baseline value Reference
P Recruitment rate 3,253,607 year1 Estimated
n Vaccination rate 0.4868 day1 Assumed
ε Vaccine efficacy 85% World Health Organization, (2017a)
u Vaccine waning rate 1/5 day1 (Centers for Disease Contr, 2010; Hepkema, Pouwels,
van der Ende, Westra, & Postma, 2013)
b Transmission probability 0.3345 day1 Fitted
h Disease modification parameter 1 Assumed
gC Recovery rate for carrier 0.1118 day
1 Fitted
gI Recovery rate for infected 0.1128 day
1 Fitted
s Disease progression rate 0.0438 day1 Fitted
k Immunity waning rate 0.0032 day1 Fitted
m Natural death rate 1/56 year1 World Health Organization, (2017c)
d Disease induced death rate 0.1923 year1 (Irving, Blyuss, Colijn, & Trotter, 2012; Vereen, 2008)
Fig. 1. Flow diagram of the meningitis model (2).
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Disease transmission models typically undergo a simple transcritical bifurcation at R 0 ¼ 1 where there is an exchange of
model's stability as the model equilibria move from the disease-free equilibrium (DFE) to an endemic equilibrium. Some
models such as vaccination models, exhibit backward bifurcation where the stable DFE co-exists with a stable endemic
equilibriumwhen the reproduction number is less than unity (see (Agusto, 2013; Agusto et al., 2013; Agusto & Gumel, 2010;
Brauer, 2004; Dushoff, Huang, & Castillo-Chavez, 1998; Elbasha & Gumel, 2006; Garba, Gumel, & Bakar, 2008; Sharomi,
Podder, Gumel, Elbasha, & Watmough, 2007; Sharomi, Podder, Gumel, & Song, 2008)). In a backward bifurcation setting,
disease control is only feasible if R 0 is reduced further to values below another sub-threshold less than unity.
The important implication of this phenomenon on public health is that the classical requirement of having the repro-
duction number less than unity, although necessary, is no longer sufficient for disease control. This means that the effective
disease control is dependent on the initial sizes of the sub-populations of the model. It is instructive, therefore, to explore
whether or not the model (2) exhibits the phenomenon of backward bifurcation. In determining this possibility in the model
(2), we use the Centre Manifold theory (Carr, 1981), as described in Theorem 4.1 by Castillo-Chavez and Song (Castillo-Chavez
& Song, 2004).
The existence of the endemic equilibria of the meningitis model (2) is given in Appendix C, while the backward bifurcation
analysis is given in Appendix D.
2.3. Parameter estimation
Here we parameterize meningitis model (2). We employ three strategies for obtaining parameter values: first we gather
the parameter values from literature (see Table 1). Second, for those parameter not found in the literature we estimate their
values when possible (see Table 1). For instance, the demographic parameter, m, is estimated as m ¼ 1=56 per year, where 56
years is the average lifespan in Nigeria (World Health Organization, 2017c). The other demographic parameter, P, is then
estimated as follows. Since the total population of Nigeria as at 2015 was 182;202;000 (World Health Organization, 2017c),
we assumed thatP =m, which is the limiting total humanpopulation in the absence of the disease, is 182;202;000, so thatP ¼
3;253;607 per year.
For those parameters we could not obtain their values by either of the above processes we fitted them based on the 2017
Nigerian meningitis outbreak data obtained from the Nigeria Centre for Disease Control (NCDC) for weeks 5e27 (Nigeria
Centre for Diseas, 2017). However, it should be noted that in the data set no public health interventions such as vaccina-
tion were used during weeks 5e27. Thus, to proceed with the parametrization, we develop in the subsection below the basic
meningitis model (3) to reflect these conditions. Before we introduce the model, we describe the data set to be used.
2.3.1. The 2017 meningitis outbreak data
The data were obtained from the Nigeria Centre for Disease Control (NCDC) (Nigeria Centre for Diseas, 2017). The NCDC
compiles weekly meningitis epidemiological report data from hospitals in affected States throughout the country. The data
include the cumulative number of cases and deaths. Fig. 2 displays the cumulative number of cases fromweeks 5 through 27.
It should be noted that no public health interventions such as vaccination were used during this period of time.
2.3.2. Basic meningitis model
To quantify the expected burden of the disease in the country, we fitted the 2017meningitis data to ameningitismodel of a
worst-case scenario where public health interventions such as vaccination or facial masks are not implemented in the
community. In the absence of such interventions, the model (2) reduces to the following basic model:
Fig. 2. Data fitting of the cumulative new cases and disease-induced mortality using the basic model (3), for the 2017 meningitis outbreaks in Nigeria (extracted
from the Nigerian Centre for Disease Control (NCDC) website (Nigeria Centre for Diseas, 2017)). The parameters fitted are given as b¼ 0:3345; gC ¼ 0:1118; gI ¼
0:1128; s ¼ 0:0438; k ¼ 0:0032.























The reproduction number for model (3) is given as:
~R 0 ¼
b½hðgI þ mþ dÞ þ s
ðsþ gC þ mÞðgI þ mþ dÞ
: (4)The method to derive this expression is similar to the one used to compute R 0 (see Appendix B) and the calculations are
given in Appendix E. The global stability of themeningitis model (3) DFE is investigated in Appendix E and the existence of the
endemic equilibrium is given in Appendix F.
To complete the parametrization of the meningitis model (2), we fit the model (3) to the 2017 Nigerian meningitis
outbreak data obtained from NCDC for weeks 5e27 (Nigeria Centre for Diseas, 2017) using the classic least-squares method.
Furthermore, The following values were taken for the initial conditions: the initial total population was taken as the pop-
ulation at the year 2015, i.e., Nð0Þ ¼ 182;202;000; the initially infected individuals as Ið0Þ ¼ 152, which is the same as the
initial number of infected in the data. We assumed Cð0Þ ¼ 1 and Rð0Þ ¼ 0, so the initial susceptible are Sð0Þ ¼ Nð0Þ Cð0Þ
Ið0Þ Rð0Þ.
The resulting fitting is shown in Fig. 2. The resulting fitted parameter values are b ¼ 0:3345; gC ¼ 0:1118; gI ¼ 0:1128;
s ¼ 0:0458 k ¼ 0:0032. Using these parameter estimates and the expression for the basic reproduction number ~R 0 in
equation (4), we obtained the value of ~R 0 for the 2017 meningitis outbreak in Nigeria as ~R 0z2:9793.
2.4. Sensitivity analysis
The outputs of deterministic models are governed by the model input parameters, which may exhibit some uncertainty in
their determination or selection. We employed a global sensitivity analysis to assess the impact of uncertainty and the
sensitivity of the outcomes of the numerical simulations to variations in each parameter of the model (2) using Latin Hy-
percube Sampling (LHS) and partial rank correlation coefficients (PRCC). LHS is a stratified sampling without replacement
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parameter (Blower& Dowlatabadi, 1994; Marino, Hogue, Ray,& Kirschner, 2008; McKay, Beckman,& Conover, 2000; Sanchez
& Blower, 1997). PRCCmeasures the strength of the relationship between the model outcome and the parameters, stating the
degree of the effect that each parameter has on the outcome (Blower & Dowlatabadi, 1994; Marino et al., 2008; McKay et al.,
2000; Sanchez & Blower, 1997). Thus, sensitivity analysis determines the parameters with the most significant impact on the
outcome of the numerical simulations of the model (Blower & Dowlatabadi, 1994; Marino et al., 2008; McLeod, Brewster,
Gumel, & Slonowsky, 2006). To generate the LHS matrices, we assume that all the model parameters are uniformly
distributed. Then a total of 1000 simulations of the models per LHS runwere carried out. The initial conditions used are stated
in Section 1.3, the baseline values are given in Table 1, and the ranges were chosen as 20% from the baseline values (in either
direction). The response functions used are the basic reproduction numbers R 0 and ~R 0, for model (2) and (3), respectively.
The range for ε is taken as 85%e100% (World Health Organization, 2017a).
To identify the parameters with the most significant impact on the reproduction numbers ( ~R 0 and R 0), the model
outcomes, we used Latin Hypercube Sampling (LHS) and partial rank correlation coefficients (PRCC) methods. From Fig. 3, it
follows that the parameters that have the most influence on the reproduction numbers are the transmission probability per
contact (b), the recovery rate of the carrier population (gC), the vaccine efficacy rate (ε), and the disease progression rate (s).
Identification of these critical parameters is essential to the formulation of effective control strategies for combating the
spread of disease. In particular, the results of this sensitivity analysis suggest that a strategy that reduces the transmission
probability per contact (i.e., reduces b), will adequately mitigate the spread of meningitis in the community. Furthermore, a
strategy that increases the vaccine efficacy (increase ε) and increases the recovery rates (increase gC) will be useful in cur-
tailing the spread of meningitis in the community.
2.5. Quantifying the expected disease burden
To quantify the expected burden of the disease in the country (under the worst-case and vaccination scenarios), the
distribution profile of ~R 0 and R 0 is generated, using the parameter values in Table 1 and the parameters in the parameter
space generated from the sensitivity analysis.
The results obtained, depicted in Fig. 4, show the distribution of the reproduction number in the range ~R 02
½1:7414;3:4624 (with a mean ~R 0z2:4754, suggesting the potential for a larger meningitis outbreaks, where one infected
case infects, on average, about 2.4754 others). However, when vaccination program is implemented, the distribution of R 0,
decreases toR 02½0:2257;1:1973, with a mean of R 0z0:5877<1 (indicating the possibility of eliminating the disease with
the use of vaccination). It is evident from Fig. 4 that the disease burden associated with the worst-case scenario is three times
more than the vaccination case. Furthermore, it is worth noting that for the worst-case scenario, the central 50% of the
generated ~R 0 values are concentrated in the interval ð2:2137;2:6960Þ, with the median of ~R 0 ¼ 2:4624 close to the mean
value. For the vaccination case, the central 50% of the generated R 0 values are concentrated in the interval ð0:4217;0:7323Þ,
with the median around R 0 ¼ 0:5737. These simulations emphasize the importance of vaccination in curtailing meningitis
outbreak in Nigeria.
Hence, we obtained in this study, that the value of ~R 0 for the 2017 meningitis outbreak in Nigeria is ~R 0z 2:9793 (see
Section 1.3) and the distribution of the reproduction number is in the range ~R 02½1:7414;3:4624 (with amean ~R 0z 2:4754)
for the estimated worst-case scenario. Using the parameters in Table 1 with vaccination as a public health intervention, and
the formula for R 0 in (1.1), we estimated the reproduction number as R 0 ¼ 0:5737, which is within the estimated interval
ð0:4217;0:7323Þ.
In the next section, we apply optimal control theory using results from the sensitivity analysis to determine the optimal
vaccination control strategy that will effectively curtail the spread of meningitis in the community.Fig. 3. PRCC values for the meningitis models (3) and (2), using as response functions: (a) The reproduction number ~R 0; and (b) The reproduction number R 0.
Parameter values (ranges) used are as given in Table 1.
Fig. 4. The box plot of the reproduction numbers (R 0 and ~R 0) for the model (2) and (3). Parameter values (baseline) and ranges used are as given in Table 1.
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The result of the sensitivity analysis suggests that a control strategy capable of reducing the transmission probability per
contact (i.e., reduces b) will adequately reduce the spread of meningitis in the community. Furthermore, a strategy that
increases the vaccine efficacy (increase ε) and the recovery rates (increase gC and gI) will be effective in curtailing the spread
of meningitis in the community.
Among the parameters identified above, the transmission probability b is the one that can be easily manipulated. For
example, it can be reduced by decreasing the contact between susceptible individuals and infected using personal protection
such as wearing of facial mask. Thus, we introduce into the transmission model (2) a time-dependent control variable umðtÞ
(representing the use of facial mask) that impacts the transmission probability b: Additionally, we assume that everyone in
the community wears facial masks regardless of their vaccine status, which affects the transmission probability indirectly.
This assumption is akin to the use of bed-nets in somemalaria diseasemodels (Agusto et al., 2013; Blayneh, Gumel, Lenhart,&
Clayton, 2010; Okosun, Rachid, & Marcus, 2013).
However, ensuring adequate compliance might be challenging since these masks might not be too comfortable to wear
particularly for long hours due to the “heat inside a facepiece” (Canini et al., 2010; Skaria & Smaldone, 2014). Nonetheless,
these masks can be worn for as long as 8 h (Centers for Disease Contr, 1997), just as long as sleeping underneath a bednet in a
typical night. On the other hand, there are comfortable masks that can be worn with ease and comfort.
We also consider as a time-dependent control variable the vaccination rate (uvðtÞ) which was previously taken as a
constant parameter (n). Although this parameter does not significantly impact the reproduction number ð ~R 0Þ, we never-
theless consider this parameter as time-dependent variable since the vaccine efficacy (ε) have a significant impact on the
ðR 0Þ. The incorporation of the time-dependent control variable umðtÞ and uvðtÞ into the model (2) yields:
dS
dt






¼ lðtÞSþð1 εÞlðtÞV  ½sþgC þmC
dI
dt









A1C þ A2I þ A3u2mðtÞ þ A4u2v ðtÞ
o
dt (6)
subject to the differential equation (5), where tf is the final time. This performance specification involves minimizing the
numbers of carriers and infectious individuals, along with the cost of applying the controls (umðtÞ;uvðtÞ). In this paper, the
controls umðtÞ, and uvðtÞ in the objective functional are quadratic since the costs of these interventions are nonlinear. This
assumption is based on previous works suggesting that there are no linear relationships between the effects of interventions
and the cost of the intervention of the infective populations. Additionally, such quadratic costs have been frequently used
(Joshi, 2002; Jung, Lenhart, & Feng, 2002; Kern, Lenhart, Miller, & Yong, 2007; Kirschner, Lenhart, & Serbin, 1997; Lenhart &
F.B. Agusto, M.C.A. Leite / Infectious Disease Modelling 4 (2019) 161e187168Workman, 2007; Yan& Zou, 2008). The coefficients, Ai; i ¼ 1;/;4, are balancing cost factors or weights on the costs.We seek



















/ ½av; bv; are Lebesgue measurable
o
;
where am; av; bm; bv are the lower and upper bounds of controls umðtÞ, and uvðtÞ. The derivation of these bounds are discussed
in Section 2.1.The controls (umðtÞ;uvðtÞ) are a bounded Lebesgue integrable functions (Jung et al., 2002; Yan & Zou, 2008). The
characterization of the controls are given in Appendix G and the study shows that the optimal control pair ðum;uv Þ mini-




























(7)2.7. Setting bounds on the controls umðtÞ, and uvðtÞ
The time dependent control umðtÞ represents personal protection. This control lies between 0 um  1. Observe that if
um ¼ 0, then the use of personal protection such as facial masks is ineffective while if um ¼ 1 such personal protection
measures are 100% effective. Thus, we set the lower bound of the control umðtÞ to am ¼ 0 and the upper bound to bm ¼ 1.
The control uv represents vaccination rate. Vaccination rates for many diseases ranges from 0 to 100%. Zero is an indication
of lack of vaccination, and 100% implies total vaccination. Although 100% total vaccination is hard to attain, there are instances
when this could be possible. For instance, this could occur if available vaccine dosage is more than the targeted population
(Lopalco & Carrillo Santisteve, 2014). Unfortunately, in some communities in sub-Saharan Africa, it is hard to attain 100%
coverage due to factors like economic reasons and displacement from wars. However, 100% coverage has been achieved for
most childhood diseases (Tsega et al., 2016). Hence, we assumed that control uvðtÞ is bounded above at one (i.e., bv ¼ 1) and
below at zero (i.e., av ¼ 0); thus uvðtÞ lies between zero and one, that is, 0 uv  1; where 1 indicates 100% vaccination rate.
Next, we discuss the numerical solutions obtained from the corresponding optimal control problem consisting of (5)
together with (6); the interpretations from various strategies considered and their corresponding implications for diseases
control.
3. Numerical simulations
The computations of the optimal controls and state values were performed using a Runge-Kutta method of the fourth
order. The algorithm is summarized as follows: first, an initial estimate for the control pair is made. Then the state variables
are solved forward in time using the dynamics (5). The results obtained for the state variables are plugged into the adjoint
equations (G-2). These adjoint equations with given final conditions (G-4) are then solved backward in time, employing the
backward fourth-order Runge-Kuttamethod. Both the state and adjoint values are then used to update the control (7), and the
process is repeated until the current state, adjoint, and controls values converge sufficiently, that is, convergence is achieved
within a pre-set tolerance value (Lenhart & Workman, 2007).
To illustrate the optimal control strategies, we mimic a small village in one of the affect States in Nigeria. In particular, we
consider the population of Zamfara State one of theworse hit states (Nigeria Centre for Diseas, 2017). The estimated 2011 total
population of the state is 3;838;160 (Wikipedia, 2018). We mimic a small village in this state by taking the statewide
population and divide it by 1000. That is, the population of this small village is about 3;838:160z3;838. To set the initial
conditions we split 3;838:160 into the classes I;V ;C;R; S as follows. The initial infected population is Ið0Þ ¼ 152, which is the
Ið0Þ value in the data set taken from NCDC. We assume that initial population of vaccinated individuals is Vð0Þ ¼ 191:908z
192. The initial population of carriers is Cð0Þ ¼ 479:77z480, and the initial recovered population is Rð0Þ ¼ 383:816z 384.
Hence, the initial susceptible population is calculated as Sð0Þ ¼ Nð0Þ Vð0Þ Cð0Þ Ið0Þ Rð0Þ ¼ 2;630:612z2;631. For the
weight factors we choose A1 ¼ A2 ¼ A3 ¼ A4 ¼ 1:0. It should be pointed out that the values of the weights used in the
simulations are theoretical as they were chosen only to illustrate the control strategies proposed in this paper.
On vaccine efficiency, the World Health Organization indicate that one dose of the vaccine has a short life efficacy ranging
from 85% to 100% in older children and adults (World Health Organization, 2017a). Thus, we set the vaccine efficacy to be ε ¼
0:95. Additionally, we set the waning rate to be five years post-vaccination because this is the value reported for young
adolescents (Centers for Disease Contr, 2010; Hepkema et al., 2013). We assume a vaccination rate n ¼ 0:4868 because this
part of the country is experiencing violent attacks by arm bandits and Boko Haram the Islamist terrorist group; as a result, the
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Reporters, 2019). The reproduction number in the absence of intervention is ~R 0z2:9793, this was calculated in Section
1.4 using the estimated and fitted parameter values in Table 1. This value indicates the epidemic nature of the disease in the
population.
The simulations of the state variables of the meningitis model (5), with and without implementing the optimal control is
given in Fig. 5. We have set the simulation period at 180 days to be consistent with the range of days in the data set we have
used. Although, simulation period is 15 days more than the number of days from the data; the cumulative number of cases
were obtained from the simulated weeks 5 through 27. With optimal control, most of the susceptible populace are either
protected or vaccinated from the bacteria (see Fig. 5(a) and (b)) thereby leading to fewer individuals at the risk of infection
(see Fig. 5(c)) and eventually resulting in fewer individuals recovering from the infection as shown in Fig. 5(d). This is not the
case in the absence of the control strategy. There are more infectious (carrier and infected) individuals present due to the fact
that more susceptible are unprotected, that is, they lack either the use of facial mask or vaccination. Consequently, there are
more recovered individuals.
The corresponding simulated time-dependent controls (umðtÞ and uvðtÞ) are depicted in Fig. 6. The time-dependent
controls umðtÞ is at the upper bound, um ¼ 1, for about 35 days before decreasing to the lower bound at the end of the
simulation period; while the control uvðtÞ starts at a lower rate of 0.12 and slowly increase to a maximum of about 0.67 at day
36 and gradually decreasing over time. These results suggest that to prevent an outbreak, individuals in the community
should continually wear these facial or surgical masks at the beginning of the season but they should gradually get vaccinated.
The result further suggests that vaccination of the populace should be maintained at a relatively low level of 0.67 for about 80
days of the simulation period. Additionally, the results indicate that to maintain the population protected from the diseases,
both the vaccination and the personal protection need to be kept at a relatively high level.Fig. 5. Simulation results of model (5) with controls. (a) Susceptible individuals; (b) Vaccinated individuals; (c) Infectious individuals (Carrier and Infected); and
(d) Recovered individuals.
Fig. 6. Simulation results of the control profile of model (5).
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personal protection like facial masks and vaccination. We found that the total number infectious (infected and carrier) in-
dividuals can be reduced in the community by the application of personal protection time-dependent controls.
3.1. Varying cost weight associated with controls umðtÞ and uvðtÞ
In this section, we investigate the effect of varying A3 and A4. These coefficients are the balancing cost factors or weights on
the costs of implementing the controls umðtÞ and uvðtÞ. Changes in them give a distinct cost of implementing the control
strategies.
3.2. Varying the weight A3 associated with control umðtÞ
First, we vary the weight A3 on the control umðtÞ representing the use of personal protection such as facial or surgical
masks. We use the weights A3 ¼ 0:10, A3 ¼ 1:00, A3 ¼ 10:0, and A3 ¼ 100, the weight A4 on control uv is kept at the baseline
value of one (i.e., A4 ¼ 1). These costs correspond to the cases with very cheap, cheap, expensive and very expensive facial
masks. The solution profiles for the state variables of the model (5) are similar to the profiles depicted in Fig. 5 and are
therefore not shown here. The solution profiles are depicted in Fig. 7.
Fig. 7 show that as the weight A3 increases from low to high (i.e., from cheap to very expensive cost), control umðtÞ de-
creases from the upper bound to levels very close to the lower bound. Also, vaccine control uvðtÞ increases to the upper bound
when the weight A3 are very high (i.e., very expensive cost). This reciprocal relationship between the weight A3 and control
uvðtÞ help to keep the community protected and the infection low as observed in Fig. 5.
3.3. Varying the weight A4 associated with control uvðtÞ
Next, we vary the weight A4 on control uvðtÞ and maintain the weight A3 on control um at the baseline value of one (i.e.,
A3 ¼ 1). We use the weights A4 ¼ 0:10, A4 ¼ 1:00, A4 ¼ 10:0, and A4 ¼ 100. These costs correspond to very cheap, cheap,
expensive and very expensive vaccine, respectively. The profile of the control solutions are depicted in Fig. 8. The solution of
the state variables are similar to those observed in Fig. 5 and are also not show here.
At low A4 values (i.e., A4 ¼ 0:10) which corresponds to a very low cost of applying the vaccination, the control uvðtÞ is
usually at the upper bound and above the control umðtÞ on facial mask. However, as A4 increases (indicating more expensive
vaccination process), the level of the control uvðtÞ falls below the control umðtÞ.
This reciprocal relation between the weight A4 and control umðtÞ is not as strong or obvious as the reciprocal relationship
observed for A3 and control mv (see Fig. 7). Note, this relationship helps to keep the community protected and the infection
low as observed in Fig. 5.
4. Cost-effectiveness analysis
Controlling and eradicating diseases in a community can be both labor intensive and expensive. Hence, to determine the
most cost-effective strategy to use, it is imperative to carry out a cost-effectiveness analysis. In this section, we apply cost-
effectiveness analysis to investigate the cost-effectiveness associated with the use of vaccination and personal protection
control strategies, and the associated benefits gained from implementing these controls (Agusto, 2013; Agusto & ELmojtaba,
2017). To this end, we consider the following combination of time-dependent controls making up three control strategies A-C:
1. Strategy A: combination of umðtÞ and uvðtÞ
Fig. 7. Simulation results of the control profile of model ((5)) using cost weights (a) A3 ¼ 0:10; (b) A3 ¼ 1:00; (c) A3 ¼ 10:0; and (d) A3 ¼ 100.
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3. Strategy C: control uvðtÞ-only while setting umðtÞ ¼ 0.
alongwith the baseline cost weights A1 ¼ A2 ¼ A3 ¼ A4 ¼ 1:0. The cost-effective analysis will be implemented using three
approaches; namely, the infection averted ratio (IAR), the average cost-effectiveness ratio (ACER) and the incremental cost-
effectiveness ratio (ICER) (Agusto, 2013; Agusto & ELmojtaba, 2017).
4.1. Infection averted ratio
The infection averted ratio (IAR) is stated as:
IAR ¼ Number of infection averted
Number of recovered
: (8)The number of infection averted is the difference between the total infectious individuals over the simulation period in the
absences of control and the total infectious individuals with control. The strategy with the highest ratio is the most cost-
effective.
4.2. Average cost-effectiveness ratio (ACER)
The average cost-effectiveness ratio (ACER) is calculated against the no intervention scenarios. The ACER is calculated as
ACER ¼ Total cost produced by the intervention
Total number of infection averted
: (9)The total cost produced by the intervention is estimated using the objective function given in (6).
Fig. 8. Simulation results of the control profile of model (5) using cost weights (a) A4 ¼ 0:10; (b) A4 ¼ 1:00; (c) A4 ¼ 10:0; and (d) A4 ¼ 100.
F.B. Agusto, M.C.A. Leite / Infectious Disease Modelling 4 (2019) 161e1871724.3. Incremental cost-effectiveness ratio
The incremental cost-effectiveness ratio (ICER) is the additional cost per additional health outcome. We assume that the
costs of the various control interventions are directly proportional to the number of controls deployed. To compare two or
more competing intervention strategies incrementally, one intervention is compared with the next-less-effective alternative
(Agusto, 2013; Agusto & ELmojtaba, 2017). Thus, the ICER is calculated as
ICER ¼ Difference in infection averted costs in strategies i and j
Difference in total number of infection averted in strategies i and j
: (10)The ICER numerator includes (where applicable) the differences in the costs of disease averted or cases prevented, the
costs of intervention(s), and the costs of averting productivity losses among others. The ICER denominator, on the other hand,
is the differences in health outcomeswhichmay include the total number of infections averted or the number of susceptibility
cases that are prevented from becoming carriers or infected.
4.4. Cost-effectiveness analysis: varying weights
Next, we compare the impact of varying the weights A3; A4 on the infection averted ratio (IAR), average cost-effectiveness
ratio (ACER), infection averted, and total cost. We use the control weights A3 ¼ 0:10, A3 ¼ 1:00, A3 ¼ 10:0, and A3 ¼ 100
keeping A4 ¼ 1, which is the baseline value. Similarly, we use A4 ¼ 0:10, A4 ¼ 1:00, A4 ¼ 10:0, and A4 ¼ 100 at the baseline
value of A3 ¼ 1. The results of simulations are in Fig. 9, where the bar graphs of the two weights A3 and A4 for the different
cost-effectiveness metric are plotted together.
When the weights are low, the two controls avert more infections (see Fig. 9(a), the blue bar in the first column of Fig. 9(a)
corresponds to A3 ¼ 0:10, while the magenta bar is A4 ¼ 0:10), but with vaccine averting slightly more infections than facial
Fig. 9. Simulation results of model (5) using control weights A3 ¼ 0:10, A3 ¼ 1:00, A3 ¼ 10:0, and A3 ¼ 100 when A4 ¼ 1, the baseline value (the turquoise
colored bars). Similarly, using A4 ¼ 0:10, A4 ¼ 1:00, A4 ¼ 10:0, and A4 ¼ 100 at the baseline value of A3 ¼ 1 (the magenta colored bars). (a) Infection averted; (b)
Infection averted ratio (IAR); (c) Average cost-effective ratio (ACER); and (d) Total cost.
F.B. Agusto, M.C.A. Leite / Infectious Disease Modelling 4 (2019) 161e187 173masks. This is clearly shown in Fig. 9(b), where the bar graph of the ratio of the infection averted is plotted for the different
weights. Furthermore, from Fig. 9(a) and (b), we observed that higher weights led to fewer infections being averted.
The results depicted in Fig. 9(c) and (d) are expected, lower weights are more cost-effective than higher weights; sur-
prisingly, vaccine led to lower cost at higher weights. This is because vaccination offers better protection with fewer infected
at the end of the simulation period. Another factor that may explain such a result is our assumption that everyone in the
community uses facial masks regardless of their vaccine status.
4.5. Cost-effectiveness analysis: control strategies A-C
The results of the optimal control simulations of problems (5), and (6) using Strategies A-C are depicted in Fig.10. The three
control strategies led to a situation in which most of the susceptible population is either protected or vaccinated from the
bacteria (see Fig. 10(a) and (b)). Strategy A produced the most vaccinated; this is because the use of facial mask offers some
level of protection to some vaccinated individuals in the population who would have been infected since the vaccine is not
100% effective.
Strategy A and B led to fewer infected and recovered while Strategy C resulted in more infected (infectious and carriers)
and recovered (see Fig. 10(c) and (d)). This result shows the impact of the use of facial masks in protecting the entire populace
during the outbreak.
The corresponding time-dependent controls (umðtÞ and uvðtÞ) for strategies A-C are depicted in Fig. 11. To ensure the level
of protection observed in Fig. 10, the control profiles for Strategy A are required to be complementary (see the red and black
solid lines in Fig. 11) this is because control umðtÞ is required to start at the upper bound for about 37 days before gradually
reducing to the lower bound, while control uvðtÞ starts at 0.35 and slowly reaching 0.69 in about 39 days. Notice that after 60
days control uvðtÞ is high while control umðtÞ is low, hence the reciprocal relationship earlier mentioned.
Fig. 10. Simulation results of model (5) with and without. (a) Susceptible individuals; (b) Vaccinated individuals; (c) Infectious individuals (Carrier and Infected);
and (d) Recovered individuals.
Fig. 11. Simulation results of the control profile of model (5).
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65 and 54 days respectively. Control umðtÞ stays higher at about 0.70 until the end of the simulation period. Thus, when either
strategy B or strategy C is in place, to obtain the level of protection observed in the community while using Strategy A, high
level of compliance is required for control umðtÞ.
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Using the parameter values in Table 1, the IAR for each intervention strategy was determined. Table 2 gives the IAR for the
three strategies implemented.
According to this cost-effectiveness analysis method, Strategy B involving personal protection (umðtÞ-only with uvðtÞ ¼ 0)
have the highest infection averted ratio and the least total cost; therefore it is the most cost-effective. The next less cost-
effective measure is Strategy A involving the combination of personal protection (umðtÞ) such as the use of facial or surgi-
cal masks and vaccination (uvðtÞ). Strategy C involving vaccination of susceptible individuals in the community is the least
cost-effective. This is due to the relatively low number of infection averted and a higher total cost (see Table 2).
4.5.2. Average cost-effectiveness ratio (ACER)
Based on this cost-effectiveness approach, the most cost-effective strategy is Strategy B, followed by Strategy A and the
least cost-effective strategy is Strategy C (see Table 2).
Next, to further investigate the cost-effectiveness of the distinct control strategies, we evaluate the incremental cost-
effectiveness ratio (ICER).
4.5.3. Incremental cost-effectiveness ratio.
To implement the ICER, we simulate the model for each of the three interventions strategies. Using these simulation
results, we rank the control strategies in increasing order of effectiveness based on infection averted. This ranking procedure
shows that Strategy C averted the least number of infections, followed by Strategy A, and Strategy B averts themost number of
infections (see Table 3).
The ICER is computed as follows:
ICERðCÞ¼1:1769 10
4
3:7159 104 ¼ 0:3167
6:2039 103  1:1769 104
ICERðBÞ¼
4:2751 104  3:7159 104 ¼ 0:9951:
6:1820 103  6:2039 103
ICERðAÞ¼
4:2784 104  4:2751 104 ¼ 0:6636A look at Table 3 shows a cost saving of 0.3167 for Strategy B over Strategy C; this is obtained by comparing ICER(B) and
ICER(C). The lower ICER obtained for Strategy B is an indication that Strategy C strongly dominate Strategy B; this simply
indicates that Strategy C is more costly to implement than Strategy B. Therefore, it is better to exclude Strategy C from the set
of control strategies and consider alternative interventions to implement in order to preserve limited resources. Therefore,
Strategy C is left out, and Strategy A is further compared with Strategy B. Hence, we obtain the following numerical results.
The ICER is computed as follows:
ICERðBÞ¼6:2039 10
3
4:2751 104 ¼ 0:1451:
6:1820 103  6:2039 103
ICERðAÞ¼
4:2784 104  4:2751 104 ¼ 0:6636From Table 4 we observe that Strategy B strongly dominate Strategy A. This merely implies that Strategy B is more costly
and less effective compared to Strategy A. Thus, we exclude strategy B from further consideration.
Thus, following the above analysis, we conclude that Strategy A (control um and uv) is the most cost-effective strategy
followed by Strategy B, the combination of all controls um-only. Strategy C (control uv-only) is the least cost-effective strategy
and should carefully be considered for implementation particularly in resource-limited places such as most of the com-
munities in the meningitis belt of sub-Saharan Africa.Table 2
Total infection averted, total cost, IAR and ACER for the intervention strategies A, B, and C.
Strategies Total infection averted Total Cost IAR ACER
Strategy A 4:2784 104 6:1820 103 0.3629 0.1445
Strategy B 4:2751 104 6:2039 103 0.3636 0.1451
Strategy C 3:7159 104 1:1769 104 0.2003 0.3167
Table 3
Total infection averted, total cost, and ICER for the intervention strategies A, B, and C.
Strategies Total infection averted Total Cost ICER
Strategy C 3:7159 104 1:1769 104 0.2003 0.3167
Strategy B 4:2751 104 6:2039 103 0.3636 0.1451
Strategy A 4:2784 104 6:1820 103 0.3629 0.1445
Table 4
Total infection averted, total cost, and ICER.
Strategies Total infection averted Total Cost ICER
Strategy B 4:2751 104 6:2039 103 0.3636 0.1451
Strategy A 4:2784 104 6:1820 103 0.3629 0.1445
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5.1. Discussions
There are several different serogroups of Neisseria meningitidis but only strain A, B, C, W135, X, and Y can cause epidemics
(World Health Organization, 2017b). The dominant strains in Nigeria are strains A and C (Men A and C). Nigeria experienced a
major outbreak of strain A in 2009 with over 55,000 cases which resulted in about 2500 deaths (World Health Organization,
2017d). And since 2013, there have been reported outbreaks of meningitis C in few local government areas of Kebbi and
Sokoto States in Nigeria. However, in 2015, over 2500 cases of the disease were reported across three states of the country.
And the current 2017 outbreak has led to over 9902 suspected cases and 602 deaths in 31 states of the country (Nigeria Centre
for Disease Control (NCDC), 2017b). In future work, wewill study the co-evolution of Men A and C in Nigeria and the possible
displacement of Men A by Men C.
Vaccine is a highly effective control strategy against the disease, and “can drastically reduce the magnitude of the
epidemic” (World Health Organization, 2017d). Individuals in the meningitis belt have seen some level of protection against
Men A by the use of Men A conjugate vaccine (MACV) introduced in 2010 (World Health Organization, 2017d). Over 260
million people have been vaccinated across 19 countries leading to over 57% reduction inmeningitis cases. Unfortunately, this
is not the case with Men C (United Nations Children's Fund (UNICEF), 2017; World Health Organization, 2017d). The Men C
vaccines are polysaccharide vaccines and are currently in short supply because they are being phased out in other parts of the
world (World Health Organization, 2017d). And the more effective and long-lasting conjugate vaccines are not readily and
promptly available (World Health Organization, 2017d).
Hence, it is not surprising to note that during the 2017 meningitis outbreak Nigeria experienced meningitis vaccine
shortage (British Broascasting Cooperation (BBC), 2017; News24, 2017; Nigeria Centre for Disease Control (NCDC), 2017a;
Voice of America (VOA), 2017). However, the Nigerian health ministry has beenworking closely withWHO, UNICEF and other
partners to ensure timely access to the Men C vaccines needed to respond to the outbreak and prevent further cases (Nigeria
Centre for Disease Control (NCDC), 2017a).
Thus, to ensure the protection of the population, particularly people living in hard-to-reach areas of the region, we propose
the use of facial masks. This study is the first study to identify and use facial masks as ameans to control Neisseria meningitidis.
As observed from our sensitivity analysis to adequately reduce the spread of meningitis in the community, it is vital to reduce
the transmission probability per contact (i.e., reduce b). This can be achieved through the use of measures like the wearing of
facial or surgical masks. The idea of such control measure is analogous to the use of insecticide-treated bednets that has
drastically reduced the number of malaria cases across sub-Sahara Africa.
The use of facial masks is a personal protection measure used as an infection-control strategy (Food and Drug Admini,
2017; Sim, Moey, & Tan, 2014). It creates a physical barrier against potential contaminants in the immediate environment
and prevents liquid and airborne particles from contaminating the face (Food and Drug Admini, 2017). Facial masks can offer
up to 45% protection under pseudo-steady concentration environment, while the protection varied from 33 to 100% under
expiratory emissions (Lai, Poon, & Cheung, 2011). The use of surgical and N95 masks against the transmission of SARS has an
effective level of about 68% and 91%, respectively (Jefferson et al., 2008; Sim et al., 2014).
Thus, in this study, we consider not only vaccination but also the use of personal protection like wearing facial masks. We
model these control measures by introducing into the meningitis model two time-dependent control variables. We inves-
tigated the associated benefits of the control strategies using cost-effectiveness analysis. This was achieved, using three
approaches, namely the infection averted ratio (IAR), the average cost-effectiveness ratio (ACER) and the incremental cost-
effectiveness ratio (ICER).
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implementing the controls um and uv; respectively) on IAR, ACER, infection averted, and total cost. The following values of
weights were used: A3 ¼ A4 ¼ 0:10;A3 ¼ A4 ¼ 1:00;A3 ¼ A4 ¼ 10:0, and A3 ¼ A4 ¼ 100. The results are summarized in Fig. 9.
These costs represent very cheap, cheap, expensive and very expensive facial masks and vaccines respectively. From Fig. 9(a)
and (b) we observed that lower weights could lead to fewer infections; with vaccine averting slightlymore infections than the
use of facial masks. Furthermore, both controls (um and uv) are equally cost-effective at lower weights than higher weights
(see Fig. 9(c) and (d)). It is surprising to see that facial mask control lead to higher ACER and total cost at higher weights. This is
due to the model requirement that everyone in the population uses facial masks regardless of whether they are vaccinated or
not. This requirement follows from the model assumption that the meningitis vaccine is imperfect.
According to the results from our analysis, the use of facial masks is comparable to a control strategy implementing
vaccination, as it can avert a large number of infections in the communities most impacted by meningitis (See Fig. 10). The
wearing of facial masks is not common in Africa as opposed to a common practice in Asia; nevertheless, the governments of
communities in sub-Sahara Africa should consider complementing the use of vaccinewith the use of facial masks. Particularly
in hard-to-reach villages and especially during outbreaks like the 2017 outbreak in Nigeria. Furthermore, our study shows
that the use of low-cost facial masks is very cost-effective (See Fig. 9). Therefore, the government of communities with limited
resources should encourage their citizens to wear these masks, since they will benefit tremendously from saved resources
that can be channeled into other projects of equal relevance for the communities.
Further cost analyzes were carried out on the three control strategies A-C using the baseline weights A1 ¼ A2 ¼ A3 ¼
A4 ¼ 1. Strategy A is a combination of time-dependent controls umðtÞ and uvðtÞ representing the use of facial masks and
vaccination. Strategy B involves control umðtÞ-only, that is, the use of facial mask onlywhile setting uvðtÞ ¼ 0; and Strategy C is
control uvðtÞ-only, that is, only consider the implementation of vaccination with umðtÞ ¼ 0.
Based on the results of these cost analysis, Strategies A and B averted the most number of infection; Strategy C performed
the least in averting the number of infections, which is not a surprising result. Similar conclusions follow from the result
obtained using the ACER, the IAR, and the objective functional (see Fig. 9(d) at the baseline weights). Thus, our results suggest
that Strategy A is the most cost-effective strategy to implement. Although this analysis shows that Strategy C is the least cost-
effective strategy to implement, it still did an excellent job of averting infection in the community (see Fig. 9(a) and (b)).
In summary, the result of the cost-effectiveness analysis suggests that resource-limited communities such as those in the
meningitis belt should consider using facial or surgical masks during the seasons when the prevalence of meningitis is high.5.2. Conclusions
Next, we summarize some of the main theoretical and epidemiological findings of this study. In this work, we presented a
deterministic model of a system of ordinary differential equations of meningitis infection transmission dynamics. The
developed model was parameterized using data obtained from Nigerian centers for diseases and controls (NCDC). Optimal
control theory was used to study the impact of personal protection (such as facial or surgical masks), and vaccination as
effective control measures against the epidemics. The following results were observed from our analysis and numerical
simulations:
(i) Themodel has a disease-free equilibrium (DFE) that is locally asymptotically stable if the reproduction number is less than one (R 0 <1) and unstable
otherwise (R 0 >1);
(ii) The application of time-dependent controls can reduce the total number of infected (infectious and carrier) individuals in the population;
(iii) By investigating the effect of changes in the weights A3; and A4; which corresponds to changes in the costs of implementing the controls um and uv ;
we observed that
(a) A reciprocal relation exist between the cost of facial mask use and vaccination coverage; as the cost of facial mask increases the use of vaccination
increases and vice versa.
(b) Lower weights are more cost-effective than higher weights.
(c) When the weights on the costs are low, the two controls avert more infections, but vaccine averts slightly more infections than facial masks.
(iv) Themost efficient and cost-effective control strategy is the strategy involving both control variables (that is, Strategy A). This is followed by Strategy B
(a strategy with the use of facial masks only). The Strategy C (a strategy with vaccination only) is the least cost-effective. Although vaccination
strategy is not cost-effective, it performs just as well as the other two strategies when the ability to curtail the infection is assessed.Data access statement
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A. Analysis of the meningitis model (2)
Basic qualitative properties
Positivity and boundedness of solutions
For the meningitis model (2) to be epidemiologically meaningful, it is essential to prove that all its state variables are non-
negative for all time. In other words, solutions of the model system (2) with non-negative initial data will remain non-
negative for all time t >0.
Lemma A.1. Let the initial data Fð0Þ  0 , where FðtÞ ¼ ðSðtÞ;VðtÞ;CðtÞ; IðtÞ;RðtÞÞ. Then the solutions FðtÞ of the meningitis model






where NðtÞ ¼ SðtÞþ VðtÞþ CðtÞþ IðtÞþ RðtÞ:
Proof. Let t1 ¼ supft >0 : FðtÞ>02½0; tg. Thus, t1 >0. It follows from the first equation of system (2), that
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> 0:Similarly, it can be shown that F >0 for all t >0.
For the second part of the Proof, note that 0< Sð0Þ NðtÞ;0  Vð0Þ  NðtÞ;0  Cð0Þ  NðtÞ;0  Ið0Þ  NðtÞ;0  Rð0Þ  NðtÞ.
Adding components of the model (2) gives




















Lemma A.2. The region U3R5þ is positively-invariant for the model (2) with non-negative initial conditions in R
5
þ.




 PmNHence, dNðtÞdt  0, if Nð0Þ  Pm . Thus, NðtÞ Nð0Þemt þ Pm ð1 emtÞ. In particular, NðtÞ  Pm .
Thus, the region U is positively-invariant. Furthermore, if Nð0Þ>Pm , then either the solutions enters U in finite time, or NðtÞ
approaches Pm asymptotically. Hence, the region U attracts all solutions in R
5
þ.
B. Stability of disease-free equilibrium (DFE) and the reproduction number R 0 of the meningitis model (2)
In this section, the conditions for the stability of the equilibria of the model (2) are stated. The meningitis model (2) has a
disease free equilibrium (DFE). The DFE is obtained by setting the right-hand sides of the equations in the model (2) to zero,
which is given by






mðnþ uþ mÞ;0; 0;0

:
The stability of E 0 can be established by calculating the reproduction number R 0 using the next generation operator
method on system (2). Taking C, and I as the infected compartments and then using the notation in (Van den Driessche &
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Therefore, the reproduction number is
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¼ b½hðgI þ mþ dÞ þ s½uþ mþ nð1 εÞðnþ uþ mÞðsþ gC þ mÞðgI þ mþ dÞ
:
where, r is the spectral radius.
The expressionR 0 is the number of secondary infections in completely susceptible population due to infections from one
introduced infectious individual with meningitis. Further, using Theorem 2 in (Van den Driessche & Watmough, 2002), the
following result is established.
Lemma B.1. The disease-free equilibrium (DFE) of the meningitis model (2) is locally asymptotically stable (LAS) if R 0 <1 and
unstable if R 0 >1.C. Existence of endemic equilibria of the meningitis model (2)
Let,
E 1 ¼ ðS;V;C; I;RÞ
denote the endemic equilibrium of the meningitis model (2) whereS ¼pk5k4k3½ð1 εÞlþ k2
a1l




2 þ a2lþ a3
;
C ¼ lpk5k4ð1 εÞðlþ k2 þ nÞ
a1l
2 þ a2lþ a3
;
I ¼ lspk5ð1 εÞðlþ k2 þ nÞ
a1l
2 þ a2lþ a3
;
R ¼ lpð1 εÞðlþ k2 þ nÞðgCk4 þ gIsÞ
a1l
2 þ a2lþ a3
;
(C-1)
where, a1 ¼ ð1 εÞ½k5k4k3  kðgCk4 þ gIsÞ, a2 ¼ k5k4k3½k2 þ k1ð1 εÞ  kðgCk4 þ gIsÞ½k2 þ nð1 εÞ, a3 ¼ k5k4k3ðk1k2 








2 þ b2l þ b3 ¼ 0; (C-3)
whereb1 ¼Pð1 εÞ½k5ðsþ k4ÞþgCk4 þgIs;
b2 ¼Pfk5½ðsþ k4Þ½k2 þ nð1 εÞþ k3k4ð1 εÞþ ðgCk4 þgIsÞ½k2 þ nð1 εÞg
bPk5ð1 εÞðsþhk4Þ;
b3 ¼ k5k4k3ðk2 þ nÞð1R 0Þ:From polynomial (C-3), we see that the coefficient b1 >0. Further, coefficient b3 <0 wheneverR 0 >1. Thus, the signs of b2
determines the number of possible positive real roots the polynomial (C-3) can have. This can be investigated using the
Descartes Rule of Signs on the quadratic polynomial gðxÞ ¼ c1x2 þ c2xþ c3, given in (C-3) (with x ¼ l;c1 ¼ a1; c2 ¼ a2; c3 ¼
a3). The various possibilities for the roots of gðxÞ are tabulated in Table 5.
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Number of Possible Positive Real Roots of gðxÞ when R 0 <1 and R 0 >1.Cases c1 c2 c3 R 0 Number of sign changes No of possible positive real roots(endemic equilibrium)
1 þ þ þ R 0 <1 0 0þ þ e R 0 >1 1 1
2 þ e þ R 0 <1 2 0,2þ e e R 0 >1 1 1The following results (Theorem C.1 and Lemma C.2) follow from the various possible combinations for the roots of gðxÞ in
Table 5.
Theorem C.1. The meningitis model (2) has a unique endemic equilibrium if R 0 >1 and whenever Cases 1 and 2 are satisfied.
The existence of multiple endemic equilibria when R 0 <1 (shown in Table 5) indicates the possibility of backward
bifurcation (Agusto et al., 2011, 2013; Brauer, 2004; Carr, 1981; Dushoff et al., 1998; Elbasha&Gumel, 2006; Garba et al., 2008;
Sharomi et al., 2007, 2008), a phenomenon where the disease-free equilibrium co-exist with a stable endemic equilibrium
when the associated reproduction number (R 0) is less than one.
Lemma C.2. The meningitis model (2) has at least one positive endemic equilibriumwheneverR 0 >1, and could have zero or two
positive endemic equilibria whenever R 0 <1.D. Backward bifurcation analysis of the meningitis model (2)
The phenomenon of backward bifurcation is shown using the concept of centre manifold theory on system (2). First, we
make the following changes in variables by setting S ¼ x1, V ¼ x2, C ¼ x3, I ¼ x4, and R ¼ x5. Furthermore, employing the
vector notation x ¼ ðx1;x2;x3;x4;x5Þ, the meningitis model (2) with vaccination can be reformulated in the form dx =dt ¼ Fx,





x1 þ x2 þ x3 þ x4 þ x5
 k1x1 þux2 þ kx5
dx2
dt
¼ f2 ¼ nx1 
bð1 εÞðhx3 þ x4Þx2







x1 þ x2 þ x3 þ x4 þ x5
þ ð1 εÞbðhx3 þ x4Þx2




¼ f4 ¼ sx3  k4x4
dx5
dt
¼ f5 ¼gCx3 þgIx4  k5x5;

















½bhx1 þ ð1 εÞbhx2
x1 þ x2
 k3
½bx1 þ ð1 εÞbx2
x1 þ x2
0
0 0 s k4 0
0 0 gC gI k5
1
CCCCCCCCCCCCCCA
(D-3)Consider the caseR 0 ¼ 1. Suppose that b is chosen as a bifurcation parameter. Setting R 0 ¼ 1 and solving for b using the






ðhk4 þ sÞx1 þ ð1 εÞx2
:
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parts. Hence the centre manifold theorem can be applied to analyze the dynamics of (D-1) near b ¼ b.



















































Using the result from Theorem 4.1 by Castillo-Chavez and Song (Castillo-Chavez & Song, 2004), we calculate the co-
efficients a and b as
a¼  2bðhw3 þw4Þðv2  v1Þ





2 :The coefficient b is given as follows:
b ¼ ðw4 þ hw3Þ





The coefficient b is positive since v3 > v1 and v3 ¼ v2; the presence of backward bifurcation in model (2) is determined by
the sign of coefficient a.
E. Stability analysis of the pre-intervention model (3)
Local stability of the DFE
The disease free equilibrium (DFE) of the meningitis pre-intervention model (3) is given by









The stability of ~E 0 is established by calculating the reproduction number ~R 0 using the next generation operator method
on system (3) as in Appendix B. Taking C, and I as the infected compartments, the Jacobian FP and VP matrices for new in-











s gI þmþ d

:
Therefore, the reproduction number is






¼ b½hðgI þ mþ dÞ þ sðsþ gC þ mÞðgI þ mþ dÞ
;
Using Theorem 2 in (Van den Driessche & Watmough, 2002), the following result is established.
Lemma E.1. The disease-free equilibrium (DFE) of the meningitis pre-intervention model (3) is locally asymptotically stable (LAS)
if ~R 0 <1 and unstable if ~R 0 >1.
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Theorem E.2. The DFE of the meningitis pre-intervention model (3) is globally asymptotically stable whenever ~R 0 <1.










































CCA  ðFP  VPÞ: (E-1)Using the fact that the eigenvalues of the matrix FP  VP all have negative real parts (see the local stability result given in
Lemma E.1, where rðFPV1P Þ<1 if ~R 0 <1 which is equivalent to FP  VP having eigenvalues with negative real parts when
~R 0 <1 (Van den Driessche & Watmough, 2002)), it follows that the linearized differential inequality system (E-2) is stable
whenever ~R 0 <1. Consequently, ðCðtÞ; IðtÞÞ/ð0;0Þ as t/∞. Thus, by comparison theorem (Lakshmikantham, Leela, &
Martynyuk, 1989; Smith & Waltman, 1995), ðCðtÞ; IðtÞÞ /ð0;0Þ as t/∞. Substituting C¼ I ¼ 0 in the third, and fourth
equations of the meningitis model (3) gives SðtÞ/S; RðtÞ/0. Hence, ðSðtÞ;CðtÞ; IðtÞ;RðtÞÞ/ðS;0;0;0Þ as t/ ∞ for ~R 0 <1.
Hence, the DFE ~E 0 is GAS in UP if ~R 0 <0.
F. Existence of endemic equilibrium of the pre-intervention model (3)
Let,
~E 1 ¼ ðS; C; I;RÞ
denote the endemic equilibrium of the pre-intervention model (3) whereS ¼ k5k4k3p
l½k5k4k3  kðgCk4 þ gIsÞ þ k5k4k3k1
;
C ¼ lk5k4p
l½k5k4k3  kðgCk4 þ gIsÞ þ k5k4k3k1
;
I ¼ slk5p
l½k5k4k3  kðgCk4 þ gIsÞ þ k5k4k3k1
;
R ¼ l½ðgCk4 þ gIsÞp
l½k5k4k3  kðgCk4 þ gIsÞ þ k5k4k3k1
;
(F-1)
withl ¼ bðhC þ IÞ
N
: (F-2)Substituting the expression in (F-2) into (F-3), we obtain after some computations the polynomial
d1l
 þ d2 ¼ 0;
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d2 ¼ k5k4k3p










 ~  ~ It follows from (F-0) that l >0 if and only if R 0 >1. Furthermore, l  0 if R 0  1 ( l ¼ 0 corresponds to the DFE, and
l <0 is biologically meaningless). Thus, the model (3) has a unique EEP whenever ~R 0 >1. This result is summarized below:
Theorem F.1. The meningitis model (3) has a unique endemic equilibrium whenever ~R 0 >1, and no endemic equilibrium
otherwise.G. Characterization of optimal controls



















The necessary conditions that an optimal control pair must satisfy come from Pontryagin's Maximum Principle
(Pontryagin, 1987). This principle converts (5) and (6) into a problem of minimizing pointwise a Hamiltonian H, with respect
to the controls (umðtÞ and uvðtÞ). First we formulate the Hamiltonian from the cost functional (6) and the governing dynamics
(5) to obtain the optimality conditions.
H¼A1CþA2IþA3u2m þA4u2v þ lS½PþuV þ kR lðtÞSuvðtÞSmS
þ lV ½uvðtÞSð1 εÞlðtÞV ðuþmÞV 
þ lCflðtÞSþð1 εÞlðtÞV  ½sþgC þmCg
þ lIfsCðgI þmþ dÞIgþ lR½gCCþgI Iðmþ kÞR;
where lS; lV ; lC ; lI ; lR are the associated adjoints for the states S; V ; C; I; R. The system of adjoint equations is found by
taking the appropriate partial derivatives of the Hamiltonian (G-2) with respect to the associated state and control variables.
Theorem G.1. Given an optimal control pair (um;uv ) and solutions S; V; C; I; R of the corresponding state system (5) that










¼0; where i¼ S; V ; C; I; R: (G-3)The optimality conditions is given as
vH
vuj
¼0; j ¼ 1;2
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Thus, the differential equations governing the adjoint variables are obtained by the differentiation of the Hamiltonian

































; lR tf ¼ 0;
evaluated at the optimal controls and corresponding state variables, results in the stated adjoint system (G-2) and (G-3).
Furthermore, differentiating the Hamiltonian function with respect to the control variables in the interior of the control set





























lS  lVuv ¼ 2A4 :Using the bounds on the controls, the characterization (G-4) can be derived. ∎
Remark 1. Due to the a priori boundedness of the state and adjoint functions and the resulting Lipschitz structure of the ODE's, the
uniqueness of the optimal control for small time (tf ) was obtained. The uniqueness of the optimal control quintuple follows from the
uniqueness of the optimality system, which consists of (5) and (G-2), (G-3) with characterization (G-4). The restriction on the length
of the time interval is to guarantee the uniqueness of the optimality system, the smallness in the length of time is due to the opposite
time orientations of (5), (G-2), and (G-3); the state problem has initial values, and the adjoint problem has final values. This re-
striction is very common in control problems (see (Agusto, 2013; Agusto, Marcus,&Okosun, 2012; Agusto& Lenhart, 2013; Joshi,
2002; Jung et al., 2002; Kern et al., 2007; Kirschner et al., 1997)).Appendix A. Supplementary data
Supplementary data to this article can be found online at https://doi.org/10.1016/j.idm.2019.05.003.
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